首页> 外国专利> REGIMEN AND METHODS FOR MULTIPLE SCLEROSIS TREATMENT USING OFATUMUMAB

REGIMEN AND METHODS FOR MULTIPLE SCLEROSIS TREATMENT USING OFATUMUMAB

机译:使用Otumumab的多发性硬化处理的方案和方法

摘要

FIELD: medicine; neurology.;SUBSTANCE: group of inventions relates to the field of medicine, namely to neurology, and is intended for the treatment of multiple sclerosis. The method of treatment of multiple sclerosis includes a) administration of ofatumumab to a patient according to the loading dosing regimen at a dose of 20 mg of ofatumumab per day 0 or 1, Day 7 and Day 14; and b) administration of ofatumumab to a patient according to the maintaining dosing regimen in a dose of 20 mg of ofatumumab, starting from the fourth week of the dosing regimen and then continuing every four weeks. Another embodiment provides the use of ofatumumab for the treatment of multiple sclerosis. ;EFFECT: use of the group of inventions makes it possible to increase effectiveness of multiple sclerosis treatment with a high safety profile. ;15 cl, 5 dwg, 1 ex
机译:领域:医学;神经内科。物质:发明组涉及医学领域,即神经内科,并且用于治疗多发性硬化症。多发性硬化的方法包括a)根据加载剂量治疗剂量给予患者,根据加载剂量,其剂量为每天20毫克,第7天和第14天的20毫克。 b)根据维持剂量的剂量在20毫克罂粟的剂量中给予患者,从给药方案的第四周开始,然后每四周继续一次。另一个实施方案提供了ofatumumab用于治疗多发性硬化症。 ;效果:使用本发明的使用使得可以提高具有高安全性的多发性硬化处理的有效性。 15 Cl,5 dwg,1 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号